Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.66 USD | -1.32% | -6.40% | -3.92% |
06-12 | Pfizer Prospective Treatment for Duchenne Muscular Dystrophy Fails to Meet Goals | MT |
06-12 | Pfizer's Duchenne Muscular Dystrophy Treatment Misses Endpoints | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.92% | 159B | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-0.51% | 121B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer Offers to Settle Zantac Claims for Up to $250 Million